Advanced search
Publication Cover
Patient Preference and Adherence Volume 3, 2009 - Issue
Submit an article Journal homepage
372
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?

Richard H Chapman1 US Health Economics and Outcomes Research, IMS Health, Falls Church, VA, USACorrespondence[email protected]
,
Elise M Pelletier1 US Health Economics and Outcomes Research, IMS Health, Falls Church, VA, USA
,
Paula J Smith1 US Health Economics and Outcomes Research, IMS Health, Falls Church, VA, USA
&
Craig S Roberts2 Global Outcomes Research, Pfizer Inc, New York, NY, USA
Pages 265-275 | Published online: 12 Aug 2009

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

JoAnne M Foody, Peter P Toth, Andrew M Tershakovec, Thomas Musliner, Joanne E Tomassini, Robert S Lowe, David R Neff & Harry R Davis. (2014) Efficacy and safety of ezetimibe plus atorvastatin therapy. Clinical Lipidology 9:4, pages 441-470.
Read now
José Zamorano & Jonathan Edwards. (2011) Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management. Integrated Blood Pressure Control 4, pages 55-71.
Read now

Articles from other publishers (8)

Qiran Wei, Jiting Zhou, Hongchao Li, Luying Wang, Yao Wu, Aixia Ma & Xin Guan. (2023) Medication adherence with fixed-dose versus free-equivalent combination therapies: Systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Konstantinos Tsioufis, José María Castellano Vázquez, Georgia Sykara, Franco Mondello Malvestiti & Joris van Vugt. (2021) Real-world Evidence for Adherence and Persistence with Atorvastatin Therapy. Cardiology and Therapy 10:2, pages 445-464.
Crossref
Alessia Romagnoli, Fiorenzo Santoleri & Alberto Costantini. (2021) Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life. Patient Education and Counseling 104:8, pages 2012-2017.
Crossref
Ana Baumgartner, Katarina Drame, Stijn Geutjens & Marja Airaksinen. (2020) Does the Polypill Improve Patient Adherence Compared to Its Individual Formulations? A Systematic Review. Pharmaceutics 12:2, pages 190.
Crossref
Yasunari Mano, Shota Fukushima, Hisayuki Kuroda, Hiroyuki Ohshima, Yoshinori Kato, Kaori Ohuchi, Kayoko Maezawa, Yasuyuki Momose, Shunya Ikeda & Mariko Asahi. (2015) Adherence to changing from brand-name to generic atorvastatin in newly treated patients: a retrospective cohort study using health insurance claims. Journal of Pharmaceutical Health Care and Sciences 1:1.
Crossref
Harold E. Bays, Erluo Chen, Joanne E. Tomassini, Gail McPeters, Adam B. Polis & Joseph Triscari. (2015) Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose-response model. Fundamental & Clinical Pharmacology 29:2, pages 209-218.
Crossref
Gregory Reardon, Gail F Schwartz & Sameer Kotak. (2010) Persistence on prostaglandin ocular hypotensive therapy: an assessment using medication possession and days covered on therapy. BMC Ophthalmology 10:1.
Crossref
Richard H Chapman, Jason Yeaw & Craig S Roberts. (2010) Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees. BMC Cardiovascular Disorders 10:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.